| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.89▼ | 1.89▼ | 1.89▼ | 1.88▼ | 1.87▲ |
| MA10 | 1.90▼ | 1.90▼ | 1.90▼ | 1.90▼ | 1.95▼ |
| MA20 | 1.92▼ | 1.91▼ | 1.91▼ | 1.86▲ | 2.00▼ |
| MA50 | 1.90▼ | 1.95▼ | 1.94▼ | 1.97▼ | 1.99▼ |
| MA100 | 2.03▼ | 2.00▼ | 1.99▼ | 2.02▼ | 2.14▼ |
| MA200 | 2.04▼ | 2.04▼ | 2.02▼ | 2.01▼ | 2.49▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.002▼ | -0.001▼ | -0.001▼ | 0.005▲ | -0.015▼ |
| RSI | 45.557▼ | 46.215▼ | 46.292▼ | 47.713▼ | 46.458▼ |
| STOCH | 20.370 | 17.063▼ | 16.071▼ | 33.821 | 17.703▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -60.465 | -78.417▼ |
| CCI | -87.500 | -83.081 | -84.397 | -28.195 | -62.903 |
|
Wednesday, December 10, 2025 10:18 PM
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial ...
|
|
Wednesday, December 10, 2025 10:00 PM
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today released its 2026 financial calendar: ...
|
|
Thursday, November 27, 2025 10:19 PM
Pursuant to the article L. 233-8 II of the French "Code de Commerce" and the article 223-16 of the French stock-market authorities (Autorité des Marchés Financiers, or "AMF") General ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/12/25 | 1.88 | 1.88 | 1.88 | 1.88 | 1,246 |
| 10/12/25 | 1.89 | 1.90 | 1.85 | 1.85 | 9,845 |
| 09/12/25 | 1.89 | 1.915 | 1.89 | 1.893 | 12,202 |
| 08/12/25 | 1.90 | 1.91 | 1.88 | 1.90 | 13,654 |
| 05/12/25 | 1.88 | 1.96 | 1.88 | 1.89 | 12,666 |
| 04/12/25 | 1.89 | 1.95 | 1.89 | 1.91 | 3,489 |
| 03/12/25 | 1.96 | 1.98 | 1.85 | 1.90 | 27,520 |
| 02/12/25 | 1.97 | 1.98 | 1.95 | 1.95 | 21,334 |
| 01/12/25 | 1.93 | 2.01 | 1.90 | 1.90 | 31,637 |
| 28/11/25 | 1.93 | 1.98 | 1.93 | 1.95 | 11,208 |
|
|
||||
|
|
||||
|
|